Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Developments in clinical trials and health information technology that will improve targeted therapies for patients

Dr Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, USA
Developments in clinical trials and health information technology that will improve targeted therapies for patients ( Dr Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, USA )
1 Jun 2015

Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia chromosome positive ALL

Dr William Slayton - University of Florida, Gainsville, USA
Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia chromosome positive ALL ( Dr William Slayton - University of Florida, Gainsville, USA )
1 Jun 2015

Obinutuzumab doubles remission duration in patients with relapsed, indolent non-hodgkin lymphoma

Dr Laurie Helen Sehn - BC Cancer Agency, Vancouver, Canada
Obinutuzumab doubles remission duration in patients with relapsed, indolent non-hodgkin lymphoma ( Dr Laurie Helen Sehn - BC Cancer Agency, Vancouver, Canada )
31 May 2015

Raloxifene retained approximately 81% of the effectiveness of tamoxifen in preventing invasive breast cancer

Dr Lawrence Wickerham - NRG Oncology Research Group, Pittsburgh, USA
Raloxifene retained approximately 81% of the effectiveness of tamoxifen in preventing invasive breast cancer ( Dr Lawrence Wickerham - NRG Oncology Research Group, Pittsburgh, USA )
31 May 2015

Next generation inhibitors help overcome problems of resistance in ALK positive lung cancer

Dr Ross Camidge - University of Colorado, Denver, USA
Next generation inhibitors help overcome problems of resistance in ALK positive lung cancer ( Dr Ross Camidge - University of Colorado, Denver, USA )
31 May 2015

Transarterial chemoembolization with or without sorafenib for intermediate-stage hepatocellular carcinoma

Prof Guohong Han - Xijing Hospital, Fourth Military Medical University, Xi'an, China
Transarterial chemoembolization with or without sorafenib for intermediate-stage hepatocellular carcinoma ( Prof Guohong Han - Xijing Hospital, Fourth Military Medical University, Xi'an, China )
31 May 2015

Letrozole vs observation for HR positive breast cancer

Dr Nicholas Zdenkowski - University of Newcastle, Newcastle, Australia
Letrozole vs observation for HR positive breast cancer ( Dr Nicholas Zdenkowski - University of Newcastle, Newcastle, Australia )
31 May 2015

Preventive neck lymph node surgery improves early oral cancer survival

Dr Anil D’Cruz - Tata Memorial Centre, Mumbai, India
Preventive neck lymph node surgery improves early oral cancer survival ( Dr Anil D’Cruz - Tata Memorial Centre, Mumbai, India )
31 May 2015

Preventive neck lymph node surgery improves early oral cancer survival

Dr Anil D’Cruz - Tata Memorial Centre, Mumbai, India
Preventive neck lymph node surgery improves early oral cancer survival ( Dr Anil D’Cruz - Tata Memorial Centre, Mumbai, India )
31 May 2015

Phase III study finds initial nivolumab-based treatment halts melanoma progression

Dr Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA
Phase III study finds initial nivolumab-based treatment halts melanoma progression ( Dr Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )
31 May 2015

New targeted treatments for blood cancers: Multiple myeloma, non-Hodgkin lymphoma, genomic marker mismatch repair and myelofibrosis

Dr Merry-Jennifer Markham - University of Florida, Florida, USA
New targeted treatments for blood cancers: Multiple myeloma, non-Hodgkin lymphoma, genomic marker mismatch repair and myelofibrosis ( Dr Merry-Jennifer Markham - University of Florida, Florida, USA )
30 May 2015

Targeted drug daratumumab shows promise in heavily treatment-resistant multiple myeloma

Dr Saad Zafar Usmani - Levine Cancer Institute, Charlotte, USA
Targeted drug daratumumab shows promise in heavily treatment-resistant multiple myeloma ( Dr Saad Zafar Usmani - Levine Cancer Institute, Charlotte, USA )
30 May 2015